- Home
- KPLT vs PYPD Comparison
KPLT vs PYPD Comparison
Compare KPLT & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPLT
- PYPD
- Stock Information
- Founded
- KPLT 2012
- PYPD 2008
- Country
- KPLT United States
- PYPD Israel
- Employees
- KPLT N/A
- PYPD N/A
- Industry
- KPLT Diversified Commercial Services
- PYPD Medical/Dental Instruments
- Sector
- KPLT Consumer Discretionary
- PYPD Health Care
- Exchange
- KPLT Nasdaq
- PYPD Nasdaq
- Market Cap
- KPLT 52.2M
- PYPD 60.4M
- IPO Year
- KPLT N/A
- PYPD 2020
- Fundamental
- Price
- KPLT $11.39
- PYPD $3.83
- Analyst Decision
- KPLT Hold
- PYPD Strong Buy
- Analyst Count
- KPLT 1
- PYPD 5
- Target Price
- KPLT $10.00
- PYPD $12.00
- AVG Volume (30 Days)
- KPLT 65.8K
- PYPD 96.3K
- Earning Date
- KPLT 11-12-2025
- PYPD 11-12-2025
- Dividend Yield
- KPLT N/A
- PYPD N/A
- EPS Growth
- KPLT N/A
- PYPD N/A
- EPS
- KPLT N/A
- PYPD N/A
- Revenue
- KPLT $267,101,999.00
- PYPD N/A
- Revenue This Year
- KPLT $22.88
- PYPD N/A
- Revenue Next Year
- KPLT $10.98
- PYPD N/A
- P/E Ratio
- KPLT N/A
- PYPD N/A
- Revenue Growth
- KPLT 13.04
- PYPD N/A
- 52 Week Low
- KPLT $5.08
- PYPD $2.30
- 52 Week High
- KPLT $24.34
- PYPD $3.93
- Technical
- Relative Strength Index (RSI)
- KPLT 39.32
- PYPD 68.60
- Support Level
- KPLT $11.91
- PYPD $3.10
- Resistance Level
- KPLT $12.94
- PYPD $3.50
- Average True Range (ATR)
- KPLT 0.98
- PYPD 0.17
- MACD
- KPLT 0.04
- PYPD 0.07
- Stochastic Oscillator
- KPLT 22.47
- PYPD 93.59
About KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.